Top Markets
Coin of the day
F-star Therapeutics, Inc. F-star Therapeutics, Inc.

F-star Therapeutics, Inc.

FSTX
Ранг среди акций #21013
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to inventing tetravalent bispecific antibodies for the treatment of cancer, particularly within the field of immuno-oncology. The company's primary investigational product, FS118, is currently in a Phase 2 proof-of-concept trial, evaluating its efficacy in head and neck cancer patients who have acquired resistance to PD-1/PD-L1 therapies. F-star is also advancing FS222, a bispecific antibody designed to simultaneously target the costimulatory CD137 receptor and the inhibitory PD-L1 ligand, through its initial Phase 1 human clinical study. Moreover, two additional drug candidates, FS120 and SB 11285, are undergoing Phase 1 clinical evaluation for patients with advanced malignancies. Founded in 2002, F-star Therapeutics, Inc. has its corporate headquarters situated in Cambridge, United Kingdom.
Цена акции
$7.12
Последняя синхронизация: 2023-03-08
Рыночная капитализация
$117.03M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
GB
Торговля F-star Therapeutics, Inc. (FSTX)

Категория

История цены акций F-star Therapeutics, Inc. (FSTX)
Наивысшая цена закрытия: $6.19 2023-03-01

Наименьшая цена закрытия: $7.22 2021-05-01
История цены акций F-star Therapeutics, Inc. с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2023 14.14%
2022 6.74%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH